{"gene":"NOTCH2","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1992,"finding":"NOTCH2 encodes a second mammalian Notch receptor protein containing all structural motifs characteristic of Notch proteins (EGF repeats, ankyrin repeats, transmembrane domain), with distinct spatial and temporal expression patterns from NOTCH1 in rat, indicating non-redundant functions.","method":"cDNA cloning, Northern blot, in situ hybridization","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 — original identification by molecular cloning with structural characterization; foundational paper with 321 citations","pmids":["1295745"],"is_preprint":false},{"year":1997,"finding":"The intracellular domain of NOTCH2 (Notch2IC) interacts with the repression domain of CBF1 (RBPJ), translocates to the nucleus, transactivates CBF1-responsive target genes by masking CBF1-mediated repression, activates endogenous HES-1, and blocks muscle cell differentiation — the same mechanism used by NOTCH1 and mimicked by EBV EBNA2.","method":"Co-immunoprecipitation, nuclear localization assay, luciferase reporter assay, CBF1 mutagenesis, cell differentiation assay","journal":"Journal of Virology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including interaction mapping, mutagenesis, reporter assay, and functional differentiation readout in single study","pmids":["9032325"],"is_preprint":false},{"year":1999,"finding":"Ankyrin repeats in the NOTCH2 cytoplasmic domain are indispensable for NOTCH2 function; mice homozygous for ankyrin repeat deletion show early embryonic lethality with increased apoptosis in neural tissues, without the somitogenesis defects seen in Notch1 knockouts, demonstrating non-redundant roles.","method":"Gene targeting (knock-in of beta-galactosidase replacing ankyrin repeats), X-gal staining, histology, TUNEL, in situ hybridization","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 — reconstitution via knock-in mutagenesis in vivo with multiple phenotypic readouts; 238 citations","pmids":["10393120"],"is_preprint":false},{"year":2002,"finding":"The intracellular domains of NOTCH1, NOTCH2, and NOTCH3 have markedly different transcriptional activities on HES1 and HES5 promoters; NOTCH2 ICD reduces activities of NOTCH1 and NOTCH3 ICDs when co-expressed, and relative activities depend on RBP-Jκ expression levels.","method":"Luciferase reporter assays with truncated intracellular domain constructs, RBP-Jκ co-expression","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 in vitro assay, single lab, single method","pmids":["11866432"],"is_preprint":false},{"year":2004,"finding":"Constitutively active NOTCH2 (truncated intracellular domain) promotes cell proliferation, soft agar colony formation, and xenograft growth of embryonal brain tumor cell lines, while constitutively active NOTCH1 inhibits growth — demonstrating opposite oncogenic/tumor-suppressive roles for the two paralogs in the same cellular context.","method":"Truncated constitutively active receptor expression, cell proliferation assay, soft agar colony formation, xenograft mouse model, FISH for gene amplification","journal":"Cancer Research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vitro and in vivo methods, replicated across multiple cell lines; 321 citations","pmids":["15520184"],"is_preprint":false},{"year":2008,"finding":"RANKL induces Jagged1 and NOTCH2 expression in bone marrow macrophages during osteoclast differentiation; NOTCH2 intracellular domain and NF-κB p65 interact in the nucleus and are co-recruited to the NFATc1 promoter, driving NFATc1 expression and osteoclastogenesis.","method":"shRNA knockdown, gamma-secretase inhibitor, ectopic Notch2 ICD expression, NFATc1 luciferase reporter, co-immunoprecipitation, chromatin immunoprecipitation","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including ChIP, Co-IP, reporter assay, and loss/gain-of-function in single study; 149 citations","pmids":["18710934"],"is_preprint":false},{"year":2009,"finding":"Conditional expression of activated NOTCH2 ICD in the liver differentiates hepatoblasts into biliary epithelial cells (BECs), induces formation of additional and ectopic bile ducts, and promotes BEC survival, establishing NOTCH2 as a direct regulator of BEC fate specification and tubulogenesis during intrahepatic bile duct development.","method":"Conditional transgenic mouse (Notch2ICD expression), histology, immunofluorescence, bile duct morphometry","journal":"Hepatology","confidence":"High","confidence_rationale":"Tier 2 — in vivo conditional gain-of-function with defined cellular phenotype; 95 citations","pmids":["19551907"],"is_preprint":false},{"year":2011,"finding":"DC-specific deletion of NOTCH2 ablates the splenic Esam-hi CD11b+ DC subset (which requires lymphotoxin beta receptor signaling and facilitates CD4+ T cell priming) and eliminates CD11b+CD103+ DCs in the intestinal lamina propria, demonstrating that NOTCH2 is a common differentiation signal for T cell-priming DC subsets.","method":"DC-specific conditional Notch2 knockout, flow cytometry, T cell priming assays, intestinal DC phenotyping","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — in vivo conditional knockout with defined cellular and functional phenotype; 431 citations","pmids":["22018469"],"is_preprint":false},{"year":2011,"finding":"Conditional ablation of Notch2 in the lens causes microphthalmia, disrupted fiber cell morphology, loss of anterior epithelium, denucleation defects, and cataracts; loss of Notch2 elevates Cdkn1a (p21), Ccnd2 (CyclinD2), and Trp63 while downregulating Cdh1 (E-Cadherin), and blocks lens progenitor cell survival.","method":"Conditional Notch2 knockout in lens, histology, gene expression analysis, BrdU incorporation","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 — in vivo conditional knockout with multiple phenotypic and molecular readouts","pmids":["22173065"],"is_preprint":false},{"year":2012,"finding":"Numb and Numblike co-deletion in the developing heart leads to increased Notch2 activity, hypertrabeculation, reduced compaction, and ventricular septum defects that phenocopy constitutively active Notch2 overexpression, identifying Numb/Numblike as upstream suppressors of Notch2 in myocardial compaction.","method":"Conditional Numb/Numblike double knockout, constitutively active Notch2 transgene, histology, expression profiling","journal":"Cardiovascular Research","confidence":"High","confidence_rationale":"Tier 2 — epistasis via double knockout phenocopying gain-of-function, multiple methods","pmids":["22865640"],"is_preprint":false},{"year":2013,"finding":"The NOTCH2 extracellular domain (NECD) increases NOTCH2 cell-surface abundance during kidney development and is cleaved more efficiently upon ligand binding compared to NOTCH1 ECD; this context-specific asymmetry in NICD release efficiency is further enhanced by Fringe and explains why NOTCH2 but not NOTCH1 is required for proximal nephron specification.","method":"ICD-swap knock-in mice, cell surface quantification, ligand cleavage assays, Fringe co-expression","journal":"Developmental Cell","confidence":"High","confidence_rationale":"Tier 1 — in vivo knock-in ICD swap combined with mechanistic in vitro cleavage assays; 84 citations","pmids":["23806616"],"is_preprint":false},{"year":2013,"finding":"NOTCH2-driven biliary cell fate determination and tubule formation in embryonic hepatoblasts and adult hepatocytes depends on canonical signaling through RBP-Jκ but does not require HES1, and activated NOTCH2 can reprogram adult hepatocytes into biliary cells with tubular-cystic structures.","method":"Genetic mouse models with N2IC transgene, RBP-Jκ and HES1 conditional knockouts, liver histology, lineage tracing","journal":"Hepatology","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic mouse models with rigorous epistasis analysis; 77 citations","pmids":["23315998"],"is_preprint":false},{"year":2014,"finding":"NOTCH2 and NOTCH3 signaling is activated by both Delta- and Jagged-type ligands and requires sequential cleavage by ADAM10 metalloprotease and then presenilin-1 or -2 (γ-secretase); ADAM17/TACE plays no role in ligand-induced NOTCH2 signaling.","method":"Cell-based signaling assays with ADAM10 and ADAM17 knockdown/inhibition, presenilin knockdown, ligand stimulation assays","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic dissection with multiple protease inhibitors and genetic knockdowns; 69 citations","pmids":["24842903"],"is_preprint":false},{"year":2014,"finding":"In a Kras(G12D)-driven NSCLC mouse model, Notch2 deletion dramatically increases carcinogenesis and decreases differentiation associated with upregulation of β-catenin, whereas Notch1 deletion reduces tumor formation; Notch2-deficient tumors show increased MAPK activity and undifferentiated morphology, demonstrating a tumor-suppressive differentiation function for Notch2 in vivo.","method":"Conditional Notch1 and Notch2 knockout in Kras(G12D) NSCLC model, tumor burden analysis, immunohistochemistry, MAPK activity assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — in vivo conditional knockout in an endogenous cancer model with multiple molecular readouts; 69 citations","pmids":["24509876"],"is_preprint":false},{"year":2015,"finding":"NOTCH2 ICD physically interacts with TRAF6, and this interaction suppresses the TRAF6-AKT signaling axis, thereby inhibiting EMT and metastasis in nasopharyngeal carcinoma.","method":"Co-immunoprecipitation, Western blot, immunofluorescence, mouse metastasis model, NOTCH2 overexpression/knockdown","journal":"Journal of Experimental & Clinical Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP demonstrating physical interaction plus functional rescue; single lab","pmids":["31699119"],"is_preprint":false},{"year":2015,"finding":"The intracellular domains of NOTCH1 and NOTCH2 are functionally equivalent when swapped in vivo; differences in outcomes attributed to each receptor reflect differences in signal strength (number of NICD molecules reaching the nucleus) and duration (NICD-RBPjk-MAML-DNA complex half-life), not ICD amino acid composition. Tissue-specific γ-secretase complexes influence NICD stability.","method":"In vivo ICD-swap knock-in mice analyzed across multiple tissue contexts (T cells, skin, inner ear, lung, retina), biochemical half-life measurements","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 — in vivo genetic swap across multiple tissue contexts with biochemical validation; 76 citations","pmids":["26062937"],"is_preprint":false},{"year":2015,"finding":"NOTCH2 inhibits PDGF-B-dependent vascular smooth muscle cell (VSMC) proliferation, and NOTCH2 expression is decreased by PDGF-B, while NOTCH3 promotes proliferation; NOTCH2 does not protect VSMCs from apoptosis or activate MAP kinase signaling (unlike NOTCH3), demonstrating distinct receptor-specific functions in VSMCs.","method":"NOTCH2 and NOTCH3 knockdown/overexpression in cultured VSMCs, proliferation assay, apoptosis assay, MAP kinase signaling analysis","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays with defined molecular pathway analysis; single lab","pmids":["25957400"],"is_preprint":false},{"year":2015,"finding":"Notch2 signaling in the ocular lens blocks lens progenitor cell death (apoptosis), regulates cell cycle withdrawal, and is required for secondary fiber cell differentiation; loss of Notch2 but not another receptor accounts for this function, establishing a specific requirement for Notch2 in lens morphogenesis.","method":"Conditional Notch2 knockout in lens, histology, TUNEL, BrdU, gene expression (Cdkn1a, Ccnd2, Cdh1)","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 — conditional knockout with defined molecular and cellular phenotypes, multiple readouts","pmids":["22173065"],"is_preprint":false},{"year":2019,"finding":"Id4 is a direct downstream target of NOTCH2 signaling in adult hippocampal neural stem cells (NSCs); Id4 promotes NSC quiescence by blocking cell-cycle entry, and Id4 knockdown rescues NOTCH2-induced inhibition of NSC proliferation, establishing a NOTCH2-Id4 axis that maintains NSC quiescence.","method":"Conditional Notch2 knockout, Id4 knockdown, Id4 overexpression, BrdU labeling, flow cytometry, gene expression analysis in mouse hippocampus","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 2 — in vivo epistasis with loss and gain of function, multiple genetic interventions; 80 citations","pmids":["31390563"],"is_preprint":false},{"year":2019,"finding":"Midkine binds Notch2 (identified as a candidate midkine receptor) and activates NOTCH2-HES1 signaling in neuroblastoma; midkine deficiency in MYCN-transgenic mice reduces Notch2 activation and delays tumor formation, and midkine RNA aptamer suppresses NOTCH2-HES1 signaling and tumor growth.","method":"Midkine genetic knockout in MYCN-transgenic mice, RNA aptamer treatment, xenograft, immunostaining for Notch2/HES1","journal":"Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic and pharmacological approaches; receptor identification not fully confirmed biochemically","pmids":["23243020"],"is_preprint":false},{"year":2020,"finding":"DLL1 expressed on differentiating satellite cells signals through NOTCH2 on neighboring satellite cells to maintain satellite cell self-renewal during muscle regeneration; antagonistic antibodies against DLL1 and NOTCH2 block self-renewal, establishing this ligand-receptor pair as required for proportional muscle regeneration.","method":"Single-cell RNA sequencing, in vivo antagonistic antibody treatment, satellite cell fate tracking","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 2 — in vivo antibody-mediated functional blockade with single-cell resolution characterization; 51 citations","pmids":["32023464"],"is_preprint":false},{"year":2020,"finding":"Lunatic fringe (LFNG) modification of O-fucose on EGF8 and EGF12 of NOTCH2 enhances DLL1-NOTCH2 activation; Manic fringe (MFNG) inhibits NOTCH2 activation by JAG1 and JAG2; elimination of O-fucose on EGF12 allows LFNG to inhibit JAG1-NOTCH2, and O-fucosylation on EGF9 is important for NOTCH2 trafficking to the cell surface.","method":"Cell-based Notch signaling and ligand-binding assays, site-directed mutagenesis, mass spectrometry of O-fucose sites, GXYLT1/GXYLT2 double knockout cells","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution assays combined with mutagenesis and mass spectrometry; 59 citations","pmids":["32820046"],"is_preprint":false},{"year":2020,"finding":"Xylosyl elongation of O-glucose glycans on NOTCH2 EGF repeats by GXYLT1 and GXYLT2 promotes cell surface trafficking of overexpressed NOTCH2; GXYLT1/GXYLT2 double knockout reduces secretion of NOTCH2 ECD, indicating a role for O-Glc elongation in quality control of NOTCH2.","method":"Mass spectrometry of O-Glc glycans on all 17 EGF repeats, GXYLT1/GXYLT2 double knockout cells, cell surface expression assay, in vitro secretion assay","journal":"Cells","confidence":"High","confidence_rationale":"Tier 1 — comprehensive mass spectrometry combined with genetic knockout and functional trafficking assays","pmids":["32423029"],"is_preprint":false},{"year":2021,"finding":"Induced Notch2IC expression in mature follicular B (FoB) cells re-programs them into bona fide marginal zone B (MZB) cells (confirmed by surface phenotype, localization, immunological function, and transcriptome), demonstrating Notch2 activation as a singular event sufficient to drive FoB-to-MZB trans-differentiation.","method":"Inducible Notch2IC transgene expression in FoB cells in immunocompetent wildtype mice, flow cytometry, transcriptomics, functional immunological assays","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — in vivo gain-of-function with multiple orthogonal validation methods; 36 citations","pmids":["33597542"],"is_preprint":false},{"year":2021,"finding":"In vivo Notch2 blockade in marginal zone (MZ) B cells reverses division-independent plasma cell differentiation and decreases mTORC1- and Myc-regulated gene transcription; Notch2/mTORC1 signaling in MZ B cells establishes a unique cellular state enabling rapid mitosis-independent plasma cell generation.","method":"Short-term in vivo Notch2 blockade with antibodies, Myc conditional deletion, ectopic mTORC1 activation in follicular B cells, plasma cell differentiation assays","journal":"Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 2 — in vivo pharmacological blockade plus genetic epistasis with multiple functional readouts","pmids":["34473651"],"is_preprint":false},{"year":2022,"finding":"Multinucleated myofibers express Notch2; in disuse and diabetes-induced muscle atrophy, microvascular endothelium upregulates and releases the Notch ligand Dll4, which activates muscular Notch2 without direct cell-cell contact. Inhibition of Dll4-Notch2 axis prevents muscle atrophy and promotes hypertrophy in mice.","method":"Conditional Notch2 knockout in muscle fibers, Dll4 antibody blockade, mouse models of disuse and diabetes-induced atrophy, muscle mass and fiber-type analysis","journal":"Nature Metabolism","confidence":"High","confidence_rationale":"Tier 2 — in vivo conditional knockout plus ligand blockade with defined mechanistic and phenotypic readouts; 40 citations","pmids":["35228746"],"is_preprint":false},{"year":2023,"finding":"KLHL6 is an E3 ubiquitin ligase that targets plasma membrane-associated NOTCH2 for proteasome-dependent degradation; DLBCL-associated NOTCH2 mutations result in a protein that escapes KLHL6-mediated ubiquitin-dependent proteolysis, leading to protein stabilization and activation of oncogenic RAS signaling.","method":"CRISPR-Cas9 cullin-RING ligase library screen, proteomic identification of KLHL6-NOTCH2 interaction, proteasome inhibition, mutation analysis in CHOP-resistant DLBCL","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — unbiased CRISPR screen combined with proteomics and mechanistic validation of ubiquitin-mediated degradation; 22 citations","pmids":["37235754"],"is_preprint":false},{"year":2020,"finding":"DTX3 (Deltex E3 ubiquitin ligase 3) was identified by yeast two-hybrid screening as a novel E3 ligase for NOTCH2 and promotes NOTCH2 ubiquitination and degradation in esophageal carcinoma cells.","method":"Yeast two-hybrid screening, Co-immunoprecipitation, ubiquitination assay, knockdown/overexpression functional studies","journal":"Cancer Science","confidence":"Medium","confidence_rationale":"Tier 2 — yeast two-hybrid identification confirmed by Co-IP and ubiquitination assay; single lab","pmids":["31854042"],"is_preprint":false},{"year":2019,"finding":"N-acetylcysteine (NAC) promotes NOTCH2 degradation through an Itch-dependent lysosomal pathway in glioblastoma cells, independent of its antioxidant function, thereby reducing downstream HES1 and HEY1 expression.","method":"Western blot, lysosome inhibitors, Itch E3 ligase co-expression, cell-based assays in glioblastoma","journal":"Journal of Experimental & Clinical Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway identified with pharmacological and genetic tools; single lab","pmids":["30606241"],"is_preprint":false},{"year":2018,"finding":"MINAR1 (major intrinsically disordered Notch2-associated receptor 1) physically interacts with NOTCH2, increases NOTCH2 stability and function, and inhibits angiogenesis and breast cancer growth; MINAR1 is an intrinsically disordered protein with a single transmembrane domain expressed in breast epithelium and endothelium.","method":"Co-immunoprecipitation, overexpression/knockdown, in vitro angiogenesis assay, zebrafish angiogenesis model, mouse matrigel plug, xenograft","journal":"Journal of Molecular Cell Biology","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP demonstrating physical interaction with multiple in vitro and in vivo functional readouts; single lab","pmids":["29329397"],"is_preprint":false},{"year":2010,"finding":"SCF induces Notch2 expression in human erythroblasts; functional inhibition of Notch2 or its ligand Jagged1 blocks SCF-driven erythroblast expansion and delays differentiation; dominant-negative Notch2 inhibits basal and SCF-mediated erythroblast proliferation, placing Notch2-Jagged1 signaling downstream of c-kit in SCF-mediated erythropoiesis.","method":"Dominant-negative Notch2 transduction in primary erythroblasts, Notch/Jagged1 functional inhibition, erythroblast expansion and differentiation assays","journal":"Cell Death and Differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis using dominant-negative approach in primary human cells; single lab","pmids":["20829885"],"is_preprint":false},{"year":2017,"finding":"BCL6 directly binds and represses NOTCH2 and Notch pathway gene promoters in follicular lymphoma (FL) cells; inducible Notch2 expression abrogates GC formation in mice and kills FL cells; BCL6 inhibition leads to NOTCH2 induction and FL cell death, rescued by NOTCH2 depletion — establishing BCL6 repression of NOTCH2 as essential for FL survival.","method":"ChIP-seq of BCL6 binding in primary FL cells, inducible Notch2 expression in mice, BCL6 inhibitors in xenografts and primary FL, NOTCH2 depletion rescue experiments","journal":"Cancer Discovery","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq plus multiple in vivo genetic and pharmacological interventions with rescue; 39 citations","pmids":["28232365"],"is_preprint":false},{"year":2021,"finding":"NOTCH2 blockade reduces CXCR4 expression on hematopoietic stem cells (HSCs), and NOTCH2 (via its transcriptional partner RBPJ) directly regulates CXCR4 transcription; Notch2 blockade or deficiency leads to decreased HSC quiescence, enhanced egress from marrow, and transient myeloid progenitor expansion.","method":"NOTCH2 blocking antibodies, Notch2 conditional knockout mice, RBPJ ChIP at CXCR4 promoter, flow cytometry of HSCs and progenitors","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrating direct RBPJ binding at CXCR4 promoter, combined with in vivo genetic and antibody approaches","pmids":["28729299"],"is_preprint":false},{"year":2014,"finding":"Notch2 signaling is specifically required for cytokine-induced goblet cell metaplasia in airway epithelial cells; inhibition of Notch2 (but not other Notch receptors) prevents goblet cell metaplasia induced by inflammatory cytokines both in vitro (3D culture system) and in vivo.","method":"3D airway epithelial culture screen, Notch2-specific antibody inhibition, in vivo mouse model of goblet cell metaplasia","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 2 — in vitro screen validated in vivo with receptor-specific antibody; 200 citations","pmids":["25558064"],"is_preprint":false},{"year":2024,"finding":"In antigen-activated follicular B cells, high NOTCH2 signaling drives MZB cell fate or plasmablast differentiation, while cells that turn off NOTCH2 signaling enter germinal centers; NOTCH2 signaling governs expansion of IgG1+ germinal center B cells and controls a binary fate decision between GCB and MZB cell fates.","method":"Notch2 conditional ablation and constitutive activation upon immunization, mathematical modeling, flow cytometry, B cell fate tracking","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic loss and gain of function with quantitative modeling; 14 citations","pmids":["38438375"],"is_preprint":false},{"year":2023,"finding":"The lncRNA LINC01977 physically binds RBM39 to prevent ubiquitination and degradation of NOTCH2, promoting its nuclear entry and HCC progression; IGF2BP2 (an m6A reader) stabilizes LINC01977 mRNA to maintain high levels in HCC.","method":"RNA immunoprecipitation, Co-IP, ubiquitination assay, nuclear fractionation, loss/gain-of-function in vitro and in vivo","journal":"Cell Death Discovery","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical assays; single lab study","pmids":["37198207"],"is_preprint":false},{"year":2023,"finding":"The pan-cancer 3'-tRF CAT1 binds RBPMS and displaces NOTCH2 mRNA from RBPMS, thereby inhibiting CCR4-NOT deadenylation complex-mediated NOTCH2 mRNA decay and increasing NOTCH2 expression to promote lung cancer cell proliferation and metastasis.","method":"RNA immunoprecipitation, RNA decay assay, CAT1 overexpression/knockdown, RBPMS knockdown, in vitro and in vivo tumor models","journal":"Cell Reports","confidence":"Medium","confidence_rationale":"Tier 2 — RNA-protein interaction mechanism with functional validation in vitro and in vivo; single lab","pmids":["37943661"],"is_preprint":false},{"year":2021,"finding":"Gm364 (a multi-pass transmembrane protein) directly binds and anchors the ubiquitin ligase MIB2 on the membrane; membrane MIB2 ubiquitinates and activates DLL3; activated DLL3 binds and activates Notch2, generating NICD2 that activates AKT within the cytoplasm to regulate oocyte meiosis and quality.","method":"Global Gm364 knockout in mice, Co-immunoprecipitation, ubiquitination assay, NICD2 detection, AKT activation assay, follicle and oocyte phenotyping","journal":"Cell Death and Differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo knockout with biochemical pathway dissection; single lab","pmids":["34635817"],"is_preprint":false},{"year":2022,"finding":"Jagged-1 (JAG1)/Notch2 signaling in the liver is antagonized by Delta-like 4 (Dll4)/Notch1 signaling; Jag1 deletion in desmin-positive mesenchymal cells during chemical hepatocarcinogenesis induces ectopic Dll4 expression in hepatocytes with loss of Notch2 signaling, leading to tumor progression.","method":"Hepatocyte-specific Dll4 knockout, Jag1 deletion, diethylnitrosamine-induced hepatocarcinogenesis model, immunostaining, Notch pathway target analysis","journal":"Communications Biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo conditional knockouts with epistatic analysis; single lab","pmids":["35064244"],"is_preprint":false}],"current_model":"NOTCH2 is a type I transmembrane receptor that, upon ligand (DLL or Jagged family) binding, undergoes sequential proteolytic cleavage by ADAM10 and γ-secretase (presenilin-1/2) to release its intracellular domain (N2ICD), which translocates to the nucleus, interacts with the transcriptional repressor RBPJ/CBF1 to convert it into a transcriptional activator, and induces target genes (HES1, HEY family); the strength and duration of N2ICD nuclear signaling — modulated by extracellular O-fucosylation (Fringe enzymes), cell-surface abundance (regulated by the NECD and glycosylation), and protein stability (controlled by ubiquitin ligases KLHL6 and DTX3 via proteasomal degradation) — determines context-specific outcomes including biliary epithelial specification, DC subset differentiation, marginal zone B cell fate, satellite cell self-renewal, muscle fiber homeostasis, NSC quiescence (via Id4), and osteoclastogenesis (via NF-κB/NFATc1 co-recruitment), while gain-of-function truncating mutations in NOTCH2 (as in Hajdu-Cheney syndrome and DLBCL) escape ubiquitin-dependent degradation to constitutively activate downstream oncogenic pathways."},"narrative":{"teleology":[{"year":1992,"claim":"Identification of NOTCH2 as a second mammalian Notch receptor with distinct expression patterns from NOTCH1 established that multiple non-redundant Notch paralogs exist in mammals.","evidence":"cDNA cloning and Northern blot/in situ hybridization in rat tissues","pmids":["1295745"],"confidence":"High","gaps":["Functional distinctions from NOTCH1 not yet demonstrated","Ligands and downstream targets unknown"]},{"year":1997,"claim":"Demonstration that NOTCH2 ICD binds RBPJ/CBF1, translocates to the nucleus, and activates HES1 transcription established the core canonical signaling mechanism shared with NOTCH1.","evidence":"Co-immunoprecipitation, nuclear localization assay, luciferase reporters, and myoblast differentiation blockade","pmids":["9032325"],"confidence":"High","gaps":["Upstream proteolytic activation events not defined","Whether NOTCH2 has unique transcriptional targets beyond HES1 unknown"]},{"year":1999,"claim":"Showing that loss of NOTCH2 ankyrin repeats causes embryonic lethality with neural apoptosis — distinct from NOTCH1 somitogenesis defects — proved non-redundant in vivo requirements.","evidence":"Knock-in deletion of ankyrin repeats in mice with TUNEL and histological analysis","pmids":["10393120"],"confidence":"High","gaps":["Specific cell types requiring NOTCH2 not resolved","Downstream effectors of NOTCH2 in neural survival unknown"]},{"year":2004,"claim":"Constitutively active NOTCH2 promoted brain tumor cell proliferation while NOTCH1 inhibited it, revealing that Notch paralogs can have opposing oncogenic versus tumor-suppressive roles in the same cellular context.","evidence":"Truncated ICD expression in embryonal brain tumor lines with soft agar and xenograft assays","pmids":["15520184"],"confidence":"High","gaps":["Molecular basis for opposite effects of NOTCH1 vs NOTCH2 ICD not identified","Relevance to spontaneous human tumors not established"]},{"year":2008,"claim":"Discovery that NOTCH2 ICD physically interacts with NF-κB p65 and is co-recruited to the NFATc1 promoter during osteoclastogenesis revealed a non-canonical co-activator mechanism linking NOTCH2 to bone resorption.","evidence":"ChIP, Co-IP, γ-secretase inhibition, and shRNA knockdown in RANKL-stimulated bone marrow macrophages","pmids":["18710934"],"confidence":"High","gaps":["Whether NOTCH2-NF-κB interaction occurs in other cell types unknown","Structural basis of the interaction not defined"]},{"year":2009,"claim":"Conditional NOTCH2 ICD expression converted hepatoblasts into biliary epithelial cells and induced ectopic bile ducts, establishing NOTCH2 as a direct fate switch for intrahepatic biliary specification.","evidence":"Conditional transgenic mouse with liver-specific Notch2ICD, bile duct morphometry","pmids":["19551907"],"confidence":"High","gaps":["Downstream transcriptional program executing biliary fate not fully mapped","Relationship to RBPJ dependence not tested in this study"]},{"year":2011,"claim":"DC-specific NOTCH2 deletion ablated Esam-hi CD11b+ splenic DCs and intestinal CD103+ DCs, identifying NOTCH2 as the receptor required for T cell-priming DC subset differentiation.","evidence":"DC-specific conditional Notch2 knockout with flow cytometry and T cell priming assays","pmids":["22018469"],"confidence":"High","gaps":["Ligand source and identity for DC differentiation not identified","NOTCH2 target genes in DC progenitors unknown"]},{"year":2013,"claim":"ICD-swap knock-in mice revealed that NOTCH2 specificity in proximal nephron development arises from differences in extracellular domain properties (surface abundance, cleavage efficiency, Fringe modulation) rather than ICD identity, fundamentally reframing paralog specificity as a signal-strength problem.","evidence":"ICD-swap knock-in mice, cell surface quantification, ligand cleavage assays with Fringe co-expression","pmids":["23806616"],"confidence":"High","gaps":["Structural basis for differential ECD cleavage efficiency not resolved","Whether this principle generalizes to all tissues not tested"]},{"year":2013,"claim":"NOTCH2-driven biliary reprogramming was shown to require RBPJ but not HES1, proving that HES1-independent RBPJ targets mediate biliary fate.","evidence":"Epistasis analysis using N2IC transgene with RBPJ and HES1 conditional knockouts in mouse liver","pmids":["23315998"],"confidence":"High","gaps":["Identity of the critical RBPJ-dependent, HES1-independent targets unknown"]},{"year":2014,"claim":"Enzymatic dissection showed that ligand-induced NOTCH2 activation requires ADAM10 (not ADAM17) followed by presenilin-dependent γ-secretase cleavage, defining the obligate protease cascade.","evidence":"Cell-based signaling assays with ADAM10/ADAM17 knockdown and presenilin inhibition","pmids":["24842903"],"confidence":"High","gaps":["Whether tissue-specific γ-secretase complexes differentially process NOTCH2 in vivo not resolved"]},{"year":2015,"claim":"In vivo ICD-swap across multiple tissues confirmed that NOTCH1 and NOTCH2 ICDs are functionally equivalent; paralog-specific outcomes arise from differences in NICD nuclear concentration and half-life, influenced by tissue-specific γ-secretase composition.","evidence":"Multi-tissue analysis of ICD-swap knock-in mice with biochemical half-life measurements","pmids":["26062937"],"confidence":"High","gaps":["Molecular identity of tissue-specific γ-secretase modulators unknown","How NICD half-life is set at the structural level not defined"]},{"year":2019,"claim":"Identification of Id4 as a direct NOTCH2 target in hippocampal neural stem cells, with epistatic rescue, established a NOTCH2→Id4 axis maintaining adult NSC quiescence.","evidence":"Conditional Notch2 knockout, Id4 knockdown rescue, BrdU labeling in mouse hippocampus","pmids":["31390563"],"confidence":"High","gaps":["Whether Id4 is the sole mediator of NOTCH2-dependent quiescence not excluded","Chromatin-level mechanism of Id4 activation not shown"]},{"year":2020,"claim":"DLL1 on differentiating satellite cells was shown to signal through NOTCH2 on quiescent neighbors to maintain self-renewal during muscle regeneration, defining the ligand-receptor pair governing proportional stem cell maintenance.","evidence":"Single-cell RNA-seq and in vivo antagonistic antibody treatment against DLL1 and NOTCH2","pmids":["32023464"],"confidence":"High","gaps":["Downstream transcriptional targets of NOTCH2 in satellite cells not identified","Whether other ligands contribute remains untested"]},{"year":2020,"claim":"Comprehensive glycosylation analysis revealed that Fringe enzymes modulate NOTCH2 ligand selectivity (LFNG enhances DLL1 response; MFNG inhibits JAG1/JAG2) through O-fucose modifications on specific EGF repeats, and O-glucose elongation by GXYLT1/GXYLT2 controls NOTCH2 surface trafficking.","evidence":"Mass spectrometry of O-fucose/O-glucose sites, site-directed mutagenesis, cell-based signaling assays, GXYLT1/GXYLT2 knockout","pmids":["32820046","32423029"],"confidence":"High","gaps":["In vivo relevance of individual glycosylation sites not tested","How glycosylation affects NOTCH2 folding/quality control at atomic resolution unknown"]},{"year":2021,"claim":"Activated NOTCH2 was shown to be both necessary and sufficient for marginal zone B cell fate: induced N2ICD reprogrammed follicular B cells into functional MZB cells, and NOTCH2 signaling maintained MZB identity by sustaining mTORC1/Myc programs enabling division-independent plasmablast differentiation.","evidence":"Inducible N2ICD transgene in FoB cells, in vivo NOTCH2 antibody blockade, Myc conditional deletion, flow cytometry, transcriptomics","pmids":["33597542","34473651"],"confidence":"High","gaps":["How NOTCH2 integrates with BCR signaling to make the binary GCB vs MZB decision not fully resolved","Direct transcriptional targets mediating mTORC1 activation unknown"]},{"year":2022,"claim":"Endothelium-derived DLL4 was shown to activate NOTCH2 on mature myofibers in a non-contact-dependent manner to drive muscle atrophy in disuse and diabetes, establishing a paracrine NOTCH2 role in post-developmental muscle homeostasis.","evidence":"Conditional Notch2 knockout in muscle fibers, DLL4 antibody blockade, disuse and diabetes mouse models","pmids":["35228746"],"confidence":"High","gaps":["Mechanism of non-contact DLL4 delivery (e.g. exosomes vs soluble cleavage) not defined","NOTCH2 transcriptional targets driving atrophy gene program unknown"]},{"year":2023,"claim":"An unbiased CRISPR screen identified KLHL6 as the E3 ubiquitin ligase targeting membrane-associated NOTCH2 for proteasomal degradation; DLBCL-associated NOTCH2 mutations escape this degradation, directly linking NOTCH2 protein stability control to lymphomagenesis.","evidence":"CRISPR cullin-RING ligase library screen, proteomics, proteasome inhibition, DLBCL mutation analysis","pmids":["37235754"],"confidence":"High","gaps":["Structural basis for how DLBCL mutations evade KLHL6 recognition unknown","Whether KLHL6 regulation operates in non-B cell contexts not tested"]},{"year":2024,"claim":"Quantitative in vivo analysis showed that NOTCH2 signal level governs a binary fate decision in antigen-activated B cells: high NOTCH2 drives MZB/plasmablast fate while signal extinction permits germinal center entry.","evidence":"Conditional ablation and constitutive activation upon immunization, mathematical modeling, B cell fate tracking","pmids":["38438375"],"confidence":"High","gaps":["What tunes NOTCH2 signal level in individual B cells is not defined","Whether this binary switch model applies in chronic infection or autoimmunity unknown"]},{"year":null,"claim":"Key unresolved questions include: the structural basis for differential ECD-mediated signal strength between NOTCH paralogs; the identity of NOTCH2-specific transcriptional targets (beyond HES1/Id4/NFATc1) in most tissue contexts; how tissue-specific γ-secretase complexes tune NICD stability; and the full spectrum of E3 ligases controlling NOTCH2 turnover across cell types.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of NOTCH2 ECD-ligand complexes exists","Comprehensive ChIP-seq for N2ICD/RBPJ across tissues is lacking","Relative contributions of proteasomal vs lysosomal degradation pathways in vivo not systematically compared"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,3,5,11,18]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,12,20,21]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,16]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[10,21,22,26]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,5,15]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,12,20,21,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,7,8,10,23]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[7,23,24,34]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,13,26,31]}],"complexes":["NOTCH2-RBPJ/CBF1-MAML transcription complex","γ-secretase (presenilin-containing) complex"],"partners":["RBPJ","ADAM10","DLL1","JAG1","KLHL6","DTX3","RELA","MINAR1"],"other_free_text":[]},"mechanistic_narrative":"NOTCH2 is a transmembrane receptor that transduces extracellular signals into transcriptional programs governing cell fate decisions across diverse tissues, including biliary specification, marginal zone B cell commitment, dendritic cell subset differentiation, neural stem cell quiescence, satellite cell self-renewal, and osteoclastogenesis. Upon binding Delta or Jagged family ligands, NOTCH2 undergoes sequential proteolytic cleavage by ADAM10 and γ-secretase (presenilin-1/2) to release its intracellular domain (N2ICD), which enters the nucleus, converts the transcriptional repressor RBPJ/CBF1 into an activator, and induces context-dependent targets including HES1, NFATc1, Id4, and CXCR4 [PMID:9032325, PMID:24842903, PMID:18710934, PMID:31390563, PMID:28729299]. Signal strength is tuned by O-fucosylation (Fringe enzymes modulate ligand selectivity), O-glucose elongation (GXYLT1/GXYLT2 control surface trafficking), extracellular domain properties that govern cleavage efficiency, and protein turnover via the E3 ubiquitin ligases KLHL6 and DTX3 [PMID:32820046, PMID:32423029, PMID:23806616, PMID:37235754, PMID:31854042]. DLBCL-associated gain-of-function NOTCH2 mutations escape KLHL6-mediated degradation to constitutively activate oncogenic signaling, while activated NOTCH2 is sufficient to reprogram follicular B cells into marginal zone B cells and hepatocytes into biliary epithelial cells [PMID:37235754, PMID:33597542, PMID:23315998]."},"prefetch_data":{"uniprot":{"accession":"Q04721","full_name":"Neurogenic locus notch homolog protein 2","aliases":[],"length_aa":2471,"mass_kda":265.4,"function":"Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus (PubMed:21378985, PubMed:21378989). Affects the implementation of differentiation, proliferation and apoptotic programs (By similarity). Involved in bone remodeling and homeostasis. In collaboration with RELA/p65 enhances NFATc1 promoter activity and positively regulates RANKL-induced osteoclast differentiation (PubMed:29149593). Positively regulates self-renewal of liver cancer cells (PubMed:25985737)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q04721/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NOTCH2","classification":"Not Classified","n_dependent_lines":13,"n_total_lines":1208,"dependency_fraction":0.01076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NOTCH2","total_profiled":1310},"omim":[{"mim_id":"621120","title":"DELTA-LIKE NONCANONICAL NOTCH LIGAND 2; DLK2","url":"https://www.omim.org/entry/621120"},{"mim_id":"620468","title":"VERTEBRAE DEVELOPMENT-ASSOCIATED GENE; VRTN","url":"https://www.omim.org/entry/620468"},{"mim_id":"620238","title":"DEAFNESS, AUTOSOMAL RECESSIVE 120; DFNB120","url":"https://www.omim.org/entry/620238"},{"mim_id":"620215","title":"MEMBRANE INTEGRAL NOTCH2-ASSOCIATED RECEPTOR 2; MINAR2","url":"https://www.omim.org/entry/620215"},{"mim_id":"619473","title":"OCULOPHARYNGODISTAL MYOPATHY 3; OPDM3","url":"https://www.omim.org/entry/619473"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NOTCH2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q04721","domains":[{"cath_id":"2.10.25","chopping":"116-151","consensus_level":"medium","plddt":65.0536,"start":116,"end":151},{"cath_id":"2.10.25.10","chopping":"208-299","consensus_level":"medium","plddt":69.7276,"start":208,"end":299},{"cath_id":"-","chopping":"389-413_432-461_474-483","consensus_level":"medium","plddt":68.7771,"start":389,"end":483},{"cath_id":"2.10.25.10","chopping":"506-536","consensus_level":"high","plddt":65.5323,"start":506,"end":536},{"cath_id":"2.10.25.10","chopping":"557-604","consensus_level":"high","plddt":63.8081,"start":557,"end":604},{"cath_id":"-","chopping":"654-680","consensus_level":"medium","plddt":69.9681,"start":654,"end":680},{"cath_id":"2.10.25","chopping":"913-942","consensus_level":"medium","plddt":66.824,"start":913,"end":942},{"cath_id":"2.10.25.10","chopping":"1034-1201","consensus_level":"medium","plddt":69.2955,"start":1034,"end":1201},{"cath_id":"2.10.25.10","chopping":"1307-1343","consensus_level":"medium","plddt":62.8511,"start":1307,"end":1343},{"cath_id":"3.30.70.3310","chopping":"1462-1501_1539-1592_1620-1670","consensus_level":"medium","plddt":77.7975,"start":1462,"end":1670}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q04721","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q04721-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q04721-F1-predicted_aligned_error_v6.png","plddt_mean":59.41},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NOTCH2","jax_strain_url":"https://www.jax.org/strain/search?query=NOTCH2"},"sequence":{"accession":"Q04721","fasta_url":"https://rest.uniprot.org/uniprotkb/Q04721.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q04721/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q04721"}},"corpus_meta":[{"pmid":"22018469","id":"PMC_22018469","title":"Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine.","date":"2011","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/22018469","citation_count":431,"is_preprint":false},{"pmid":"1295745","id":"PMC_1295745","title":"Notch2: a second mammalian Notch gene.","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1295745","citation_count":321,"is_preprint":false},{"pmid":"15520184","id":"PMC_15520184","title":"Notch1 and notch2 have opposite effects on embryonal brain tumor growth.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15520184","citation_count":321,"is_preprint":false},{"pmid":"10393120","id":"PMC_10393120","title":"Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10393120","citation_count":238,"is_preprint":false},{"pmid":"25934888","id":"PMC_25934888","title":"Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.","date":"2015","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/25934888","citation_count":204,"is_preprint":false},{"pmid":"25558064","id":"PMC_25558064","title":"Notch2 is required for inflammatory cytokine-driven goblet cell metaplasia in the lung.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25558064","citation_count":200,"is_preprint":false},{"pmid":"30808369","id":"PMC_30808369","title":"miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization.","date":"2019","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30808369","citation_count":180,"is_preprint":false},{"pmid":"18710934","id":"PMC_18710934","title":"The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18710934","citation_count":149,"is_preprint":false},{"pmid":"11438922","id":"PMC_11438922","title":"Expression patterns of Notch1, Notch2, and Notch3 suggest multiple functional roles for the Notch-DSL signaling system during brain development.","date":"2001","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11438922","citation_count":126,"is_preprint":false},{"pmid":"29229388","id":"PMC_29229388","title":"LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29229388","citation_count":113,"is_preprint":false},{"pmid":"31343788","id":"PMC_31343788","title":"Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31343788","citation_count":112,"is_preprint":false},{"pmid":"17675579","id":"PMC_17675579","title":"Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth.","date":"2007","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17675579","citation_count":100,"is_preprint":false},{"pmid":"9032325","id":"PMC_9032325","title":"Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation.","date":"1997","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9032325","citation_count":99,"is_preprint":false},{"pmid":"8892932","id":"PMC_8892932","title":"Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma.","date":"1996","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/8892932","citation_count":98,"is_preprint":false},{"pmid":"19551907","id":"PMC_19551907","title":"Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice.","date":"2009","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19551907","citation_count":95,"is_preprint":false},{"pmid":"17080428","id":"PMC_17080428","title":"Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner.","date":"2007","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17080428","citation_count":92,"is_preprint":false},{"pmid":"11866432","id":"PMC_11866432","title":"Functional diversity among Notch1, Notch2, and Notch3 receptors.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11866432","citation_count":90,"is_preprint":false},{"pmid":"23806616","id":"PMC_23806616","title":"The extracellular domain of Notch2 increases its cell-surface abundance and ligand responsiveness during kidney development.","date":"2013","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/23806616","citation_count":84,"is_preprint":false},{"pmid":"31390563","id":"PMC_31390563","title":"Id4 Downstream of Notch2 Maintains Neural Stem Cell Quiescence in the Adult Hippocampus.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31390563","citation_count":80,"is_preprint":false},{"pmid":"23315998","id":"PMC_23315998","title":"Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1.","date":"2013","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23315998","citation_count":77,"is_preprint":false},{"pmid":"26062937","id":"PMC_26062937","title":"The intracellular domains of Notch1 and Notch2 are functionally equivalent during development and carcinogenesis.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26062937","citation_count":76,"is_preprint":false},{"pmid":"25957400","id":"PMC_25957400","title":"Differential Regulation of NOTCH2 and NOTCH3 Contribute to Their Unique Functions in Vascular Smooth Muscle Cells.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25957400","citation_count":74,"is_preprint":false},{"pmid":"24842903","id":"PMC_24842903","title":"Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24842903","citation_count":69,"is_preprint":false},{"pmid":"24509876","id":"PMC_24509876","title":"Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24509876","citation_count":69,"is_preprint":false},{"pmid":"30470250","id":"PMC_30470250","title":"miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.","date":"2018","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30470250","citation_count":68,"is_preprint":false},{"pmid":"28161537","id":"PMC_28161537","title":"miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28161537","citation_count":67,"is_preprint":false},{"pmid":"22190591","id":"PMC_22190591","title":"Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages.","date":"2011","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/22190591","citation_count":60,"is_preprint":false},{"pmid":"32820046","id":"PMC_32820046","title":"Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32820046","citation_count":59,"is_preprint":false},{"pmid":"23220650","id":"PMC_23220650","title":"P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2.","date":"2012","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/23220650","citation_count":59,"is_preprint":false},{"pmid":"28733035","id":"PMC_28733035","title":"MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28733035","citation_count":57,"is_preprint":false},{"pmid":"22865640","id":"PMC_22865640","title":"Inhibition of Notch2 by Numb/Numblike controls myocardial compaction in the heart.","date":"2012","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/22865640","citation_count":57,"is_preprint":false},{"pmid":"26293507","id":"PMC_26293507","title":"Notch1 and Notch2 in Podocytes Play Differential Roles During Diabetic Nephropathy Development.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26293507","citation_count":55,"is_preprint":false},{"pmid":"23243020","id":"PMC_23243020","title":"Midkine promotes neuroblastoma through Notch2 signaling.","date":"2012","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/23243020","citation_count":54,"is_preprint":false},{"pmid":"16840533","id":"PMC_16840533","title":"Persistent expression of Notch2 delays gonadotrope differentiation.","date":"2006","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/16840533","citation_count":53,"is_preprint":false},{"pmid":"32077168","id":"PMC_32077168","title":"Aberrant expression of miR-29b-3p influences heart development and cardiomyocyte proliferation by targeting NOTCH2.","date":"2020","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/32077168","citation_count":53,"is_preprint":false},{"pmid":"32023464","id":"PMC_32023464","title":"Heterogeneity of Satellite Cells Implicates DELTA1/NOTCH2 Signaling in Self-Renewal.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32023464","citation_count":51,"is_preprint":false},{"pmid":"31218097","id":"PMC_31218097","title":"The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31218097","citation_count":51,"is_preprint":false},{"pmid":"24574459","id":"PMC_24574459","title":"NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24574459","citation_count":47,"is_preprint":false},{"pmid":"31619270","id":"PMC_31619270","title":"JAG2/Notch2 inhibits intervertebral disc degeneration by modulating cell proliferation, apoptosis, and extracellular matrix.","date":"2019","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31619270","citation_count":46,"is_preprint":false},{"pmid":"12531696","id":"PMC_12531696","title":"Notch2 protein distribution in human teeth under normal and pathological conditions.","date":"2003","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12531696","citation_count":45,"is_preprint":false},{"pmid":"32293074","id":"PMC_32293074","title":"CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32293074","citation_count":45,"is_preprint":false},{"pmid":"30606241","id":"PMC_30606241","title":"N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/30606241","citation_count":45,"is_preprint":false},{"pmid":"26041881","id":"PMC_26041881","title":"The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26041881","citation_count":44,"is_preprint":false},{"pmid":"30670679","id":"PMC_30670679","title":"Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling.","date":"2019","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/30670679","citation_count":43,"is_preprint":false},{"pmid":"22173065","id":"PMC_22173065","title":"Conditional ablation of the Notch2 receptor in the ocular lens.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22173065","citation_count":42,"is_preprint":false},{"pmid":"35228746","id":"PMC_35228746","title":"The endothelial Dll4-muscular Notch2 axis regulates skeletal muscle mass.","date":"2022","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35228746","citation_count":40,"is_preprint":false},{"pmid":"31699119","id":"PMC_31699119","title":"NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31699119","citation_count":40,"is_preprint":false},{"pmid":"28232365","id":"PMC_28232365","title":"BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.","date":"2017","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/28232365","citation_count":39,"is_preprint":false},{"pmid":"28851699","id":"PMC_28851699","title":"An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.","date":"2017","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/28851699","citation_count":37,"is_preprint":false},{"pmid":"24508387","id":"PMC_24508387","title":"Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture.","date":"2014","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/24508387","citation_count":36,"is_preprint":false},{"pmid":"33597542","id":"PMC_33597542","title":"Notch2-mediated plasticity between marginal zone and follicular B cells.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33597542","citation_count":36,"is_preprint":false},{"pmid":"19653042","id":"PMC_19653042","title":"Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status.","date":"2009","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19653042","citation_count":35,"is_preprint":false},{"pmid":"27241678","id":"PMC_27241678","title":"Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.","date":"2016","source":"Current osteoporosis reports","url":"https://pubmed.ncbi.nlm.nih.gov/27241678","citation_count":34,"is_preprint":false},{"pmid":"29706630","id":"PMC_29706630","title":"lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29706630","citation_count":34,"is_preprint":false},{"pmid":"34473651","id":"PMC_34473651","title":"Resting innate-like B cells leverage sustained Notch2/mTORC1 signaling to achieve rapid and mitosis-independent plasma cell differentiation.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/34473651","citation_count":33,"is_preprint":false},{"pmid":"33839417","id":"PMC_33839417","title":"Silencing long non-coding RNA MEG8 inhibits the proliferation and induces the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/NOTCH2 axis.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33839417","citation_count":33,"is_preprint":false},{"pmid":"32457613","id":"PMC_32457613","title":"Circular RNA circKIF4A Sponges miR-375/1231 to Promote Bladder Cancer Progression by Upregulating NOTCH2 Expression.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32457613","citation_count":32,"is_preprint":false},{"pmid":"20971948","id":"PMC_20971948","title":"Notch2 signaling is required for proper mast cell distribution and mucosal immunity in the intestine.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20971948","citation_count":31,"is_preprint":false},{"pmid":"27221981","id":"PMC_27221981","title":"Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27221981","citation_count":30,"is_preprint":false},{"pmid":"38969159","id":"PMC_38969159","title":"Neutrophil extracellular traps promote immune escape in hepatocellular carcinoma by up-regulating CD73 through Notch2.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38969159","citation_count":29,"is_preprint":false},{"pmid":"33835684","id":"PMC_33835684","title":"Extracellular vesicle-derived microRNA-18b ameliorates preeclampsia by enhancing trophoblast proliferation and migration via Notch2/TIM3/mTORC1 axis.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33835684","citation_count":29,"is_preprint":false},{"pmid":"19339697","id":"PMC_19339697","title":"Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19339697","citation_count":28,"is_preprint":false},{"pmid":"29915190","id":"PMC_29915190","title":"Mesenchymal stem cell-mediated Notch2 activation overcomes radiation-induced injury of the hematopoietic system.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29915190","citation_count":27,"is_preprint":false},{"pmid":"31854042","id":"PMC_31854042","title":"Ubiquitination of NOTCH2 by DTX3 suppresses the proliferation and migration of human esophageal carcinoma.","date":"2020","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/31854042","citation_count":27,"is_preprint":false},{"pmid":"26453897","id":"PMC_26453897","title":"Loss of Notch2 and Notch3 in vascular smooth muscle causes patent ductus arteriosus.","date":"2015","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/26453897","citation_count":27,"is_preprint":false},{"pmid":"26018735","id":"PMC_26018735","title":"Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/26018735","citation_count":27,"is_preprint":false},{"pmid":"25659500","id":"PMC_25659500","title":"Expression pattern and function of Notch2 in different subtypes of first trimester cytotrophoblast.","date":"2015","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/25659500","citation_count":26,"is_preprint":false},{"pmid":"29581534","id":"PMC_29581534","title":"MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29581534","citation_count":26,"is_preprint":false},{"pmid":"33309869","id":"PMC_33309869","title":"Notch1 and Notch2 collaboratively maintain radial glial cells in mouse neurogenesis.","date":"2020","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/33309869","citation_count":25,"is_preprint":false},{"pmid":"23277114","id":"PMC_23277114","title":"The expression of NOTCH2, HES1 and SOX9 during mouse retinal development.","date":"2012","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/23277114","citation_count":24,"is_preprint":false},{"pmid":"34296965","id":"PMC_34296965","title":"Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation.","date":"2021","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34296965","citation_count":24,"is_preprint":false},{"pmid":"32423029","id":"PMC_32423029","title":"Xylosyl Extension of O-Glucose Glycans on the Extracellular Domain of NOTCH1 and NOTCH2 Regulates Notch Cell Surface Trafficking.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32423029","citation_count":24,"is_preprint":false},{"pmid":"28729299","id":"PMC_28729299","title":"Notch2 blockade enhances hematopoietic stem cell mobilization and homing.","date":"2017","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/28729299","citation_count":23,"is_preprint":false},{"pmid":"25954607","id":"PMC_25954607","title":"Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study.","date":"2015","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25954607","citation_count":23,"is_preprint":false},{"pmid":"37235754","id":"PMC_37235754","title":"DLBCL-associated NOTCH2 mutations escape ubiquitin-dependent degradation and promote chemoresistance.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/37235754","citation_count":22,"is_preprint":false},{"pmid":"39505846","id":"PMC_39505846","title":"Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39505846","citation_count":22,"is_preprint":false},{"pmid":"38462037","id":"PMC_38462037","title":"LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38462037","citation_count":22,"is_preprint":false},{"pmid":"23349727","id":"PMC_23349727","title":"The different role of Notch1 and Notch2 in astrocytic gliomas.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23349727","citation_count":22,"is_preprint":false},{"pmid":"28856714","id":"PMC_28856714","title":"High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.","date":"2017","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/28856714","citation_count":22,"is_preprint":false},{"pmid":"29875313","id":"PMC_29875313","title":"Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29875313","citation_count":21,"is_preprint":false},{"pmid":"20829885","id":"PMC_20829885","title":"The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesis.","date":"2010","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/20829885","citation_count":21,"is_preprint":false},{"pmid":"30988799","id":"PMC_30988799","title":"miR-758-3p suppresses human bladder cancer cell proliferation, migration and invasion by targeting NOTCH2.","date":"2019","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30988799","citation_count":21,"is_preprint":false},{"pmid":"35337368","id":"PMC_35337368","title":"The effect of mitochondrial fusion on chondrogenic differentiation of cartilage progenitor/stem cells via Notch2 signal pathway.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35337368","citation_count":21,"is_preprint":false},{"pmid":"30304577","id":"PMC_30304577","title":"Functional evidence implicating NOTCH2 missense mutations in primary ovarian insufficiency etiology.","date":"2018","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/30304577","citation_count":19,"is_preprint":false},{"pmid":"10704869","id":"PMC_10704869","title":"Correlation of asymmetric Notch2 expression and mouse incisor rotation.","date":"2000","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10704869","citation_count":19,"is_preprint":false},{"pmid":"28278511","id":"PMC_28278511","title":"Mechanism of MicroRNA-146a/Notch2 Signaling Regulating IL-6 in Graves Ophthalmopathy.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28278511","citation_count":19,"is_preprint":false},{"pmid":"31643078","id":"PMC_31643078","title":"MicroRNA-16 is involved in the pathogenesis of pre-eclampsia via regulation of Notch2.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31643078","citation_count":19,"is_preprint":false},{"pmid":"37198207","id":"PMC_37198207","title":"The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/37198207","citation_count":19,"is_preprint":false},{"pmid":"29329397","id":"PMC_29329397","title":"MINAR1 is a Notch2-binding protein that inhibits angiogenesis and breast cancer growth.","date":"2018","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29329397","citation_count":18,"is_preprint":false},{"pmid":"28666642","id":"PMC_28666642","title":"Pathobiology of Notch2 in lung cancer.","date":"2017","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28666642","citation_count":17,"is_preprint":false},{"pmid":"26427670","id":"PMC_26427670","title":"Notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma.","date":"2015","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26427670","citation_count":17,"is_preprint":false},{"pmid":"33214146","id":"PMC_33214146","title":"TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33214146","citation_count":17,"is_preprint":false},{"pmid":"37943661","id":"PMC_37943661","title":"Pan-cancer tRNA-derived fragment CAT1 coordinates RBPMS to stabilize NOTCH2 mRNA to promote tumorigenesis.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37943661","citation_count":17,"is_preprint":false},{"pmid":"32294039","id":"PMC_32294039","title":"MiR-485-5p Promotes Neuron Survival through Mediating Rac1/Notch2 Signaling Pathway after Cerebral Ischemia/Reperfusion.","date":"2020","source":"Current neurovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/32294039","citation_count":17,"is_preprint":false},{"pmid":"31992595","id":"PMC_31992595","title":"Antisense oligonucleotides targeting Notch2 ameliorate the osteopenic phenotype in a mouse model of Hajdu-Cheney syndrome.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31992595","citation_count":16,"is_preprint":false},{"pmid":"34821000","id":"PMC_34821000","title":"MicroRNA-181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/34821000","citation_count":15,"is_preprint":false},{"pmid":"34245196","id":"PMC_34245196","title":"CARMN-NOTCH2 fusion transcript drives high NOTCH2 expression in glomus tumors of the upper digestive tract.","date":"2021","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34245196","citation_count":15,"is_preprint":false},{"pmid":"34635817","id":"PMC_34635817","title":"Gm364 coordinates MIB2/DLL3/Notch2 to regulate female fertility through AKT activation.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34635817","citation_count":14,"is_preprint":false},{"pmid":"38438375","id":"PMC_38438375","title":"Notch2 controls developmental fate choices between germinal center and marginal zone B cells upon immunization.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38438375","citation_count":14,"is_preprint":false},{"pmid":"35064244","id":"PMC_35064244","title":"Two distinct Notch signals, Delta-like 4/Notch1 and Jagged-1/Notch2, antagonistically regulate chemical hepatocarcinogenesis in mice.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35064244","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49172,"output_tokens":9214,"usd":0.142863},"stage2":{"model":"claude-opus-4-6","input_tokens":13082,"output_tokens":4294,"usd":0.25914},"total_usd":0.402003,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"NOTCH2 encodes a second mammalian Notch receptor protein containing all structural motifs characteristic of Notch proteins (EGF repeats, ankyrin repeats, transmembrane domain), with distinct spatial and temporal expression patterns from NOTCH1 in rat, indicating non-redundant functions.\",\n      \"method\": \"cDNA cloning, Northern blot, in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original identification by molecular cloning with structural characterization; foundational paper with 321 citations\",\n      \"pmids\": [\"1295745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The intracellular domain of NOTCH2 (Notch2IC) interacts with the repression domain of CBF1 (RBPJ), translocates to the nucleus, transactivates CBF1-responsive target genes by masking CBF1-mediated repression, activates endogenous HES-1, and blocks muscle cell differentiation — the same mechanism used by NOTCH1 and mimicked by EBV EBNA2.\",\n      \"method\": \"Co-immunoprecipitation, nuclear localization assay, luciferase reporter assay, CBF1 mutagenesis, cell differentiation assay\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including interaction mapping, mutagenesis, reporter assay, and functional differentiation readout in single study\",\n      \"pmids\": [\"9032325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Ankyrin repeats in the NOTCH2 cytoplasmic domain are indispensable for NOTCH2 function; mice homozygous for ankyrin repeat deletion show early embryonic lethality with increased apoptosis in neural tissues, without the somitogenesis defects seen in Notch1 knockouts, demonstrating non-redundant roles.\",\n      \"method\": \"Gene targeting (knock-in of beta-galactosidase replacing ankyrin repeats), X-gal staining, histology, TUNEL, in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution via knock-in mutagenesis in vivo with multiple phenotypic readouts; 238 citations\",\n      \"pmids\": [\"10393120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The intracellular domains of NOTCH1, NOTCH2, and NOTCH3 have markedly different transcriptional activities on HES1 and HES5 promoters; NOTCH2 ICD reduces activities of NOTCH1 and NOTCH3 ICDs when co-expressed, and relative activities depend on RBP-Jκ expression levels.\",\n      \"method\": \"Luciferase reporter assays with truncated intracellular domain constructs, RBP-Jκ co-expression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 in vitro assay, single lab, single method\",\n      \"pmids\": [\"11866432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Constitutively active NOTCH2 (truncated intracellular domain) promotes cell proliferation, soft agar colony formation, and xenograft growth of embryonal brain tumor cell lines, while constitutively active NOTCH1 inhibits growth — demonstrating opposite oncogenic/tumor-suppressive roles for the two paralogs in the same cellular context.\",\n      \"method\": \"Truncated constitutively active receptor expression, cell proliferation assay, soft agar colony formation, xenograft mouse model, FISH for gene amplification\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vitro and in vivo methods, replicated across multiple cell lines; 321 citations\",\n      \"pmids\": [\"15520184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RANKL induces Jagged1 and NOTCH2 expression in bone marrow macrophages during osteoclast differentiation; NOTCH2 intracellular domain and NF-κB p65 interact in the nucleus and are co-recruited to the NFATc1 promoter, driving NFATc1 expression and osteoclastogenesis.\",\n      \"method\": \"shRNA knockdown, gamma-secretase inhibitor, ectopic Notch2 ICD expression, NFATc1 luciferase reporter, co-immunoprecipitation, chromatin immunoprecipitation\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including ChIP, Co-IP, reporter assay, and loss/gain-of-function in single study; 149 citations\",\n      \"pmids\": [\"18710934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Conditional expression of activated NOTCH2 ICD in the liver differentiates hepatoblasts into biliary epithelial cells (BECs), induces formation of additional and ectopic bile ducts, and promotes BEC survival, establishing NOTCH2 as a direct regulator of BEC fate specification and tubulogenesis during intrahepatic bile duct development.\",\n      \"method\": \"Conditional transgenic mouse (Notch2ICD expression), histology, immunofluorescence, bile duct morphometry\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional gain-of-function with defined cellular phenotype; 95 citations\",\n      \"pmids\": [\"19551907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DC-specific deletion of NOTCH2 ablates the splenic Esam-hi CD11b+ DC subset (which requires lymphotoxin beta receptor signaling and facilitates CD4+ T cell priming) and eliminates CD11b+CD103+ DCs in the intestinal lamina propria, demonstrating that NOTCH2 is a common differentiation signal for T cell-priming DC subsets.\",\n      \"method\": \"DC-specific conditional Notch2 knockout, flow cytometry, T cell priming assays, intestinal DC phenotyping\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional knockout with defined cellular and functional phenotype; 431 citations\",\n      \"pmids\": [\"22018469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Conditional ablation of Notch2 in the lens causes microphthalmia, disrupted fiber cell morphology, loss of anterior epithelium, denucleation defects, and cataracts; loss of Notch2 elevates Cdkn1a (p21), Ccnd2 (CyclinD2), and Trp63 while downregulating Cdh1 (E-Cadherin), and blocks lens progenitor cell survival.\",\n      \"method\": \"Conditional Notch2 knockout in lens, histology, gene expression analysis, BrdU incorporation\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional knockout with multiple phenotypic and molecular readouts\",\n      \"pmids\": [\"22173065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Numb and Numblike co-deletion in the developing heart leads to increased Notch2 activity, hypertrabeculation, reduced compaction, and ventricular septum defects that phenocopy constitutively active Notch2 overexpression, identifying Numb/Numblike as upstream suppressors of Notch2 in myocardial compaction.\",\n      \"method\": \"Conditional Numb/Numblike double knockout, constitutively active Notch2 transgene, histology, expression profiling\",\n      \"journal\": \"Cardiovascular Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via double knockout phenocopying gain-of-function, multiple methods\",\n      \"pmids\": [\"22865640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The NOTCH2 extracellular domain (NECD) increases NOTCH2 cell-surface abundance during kidney development and is cleaved more efficiently upon ligand binding compared to NOTCH1 ECD; this context-specific asymmetry in NICD release efficiency is further enhanced by Fringe and explains why NOTCH2 but not NOTCH1 is required for proximal nephron specification.\",\n      \"method\": \"ICD-swap knock-in mice, cell surface quantification, ligand cleavage assays, Fringe co-expression\",\n      \"journal\": \"Developmental Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vivo knock-in ICD swap combined with mechanistic in vitro cleavage assays; 84 citations\",\n      \"pmids\": [\"23806616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NOTCH2-driven biliary cell fate determination and tubule formation in embryonic hepatoblasts and adult hepatocytes depends on canonical signaling through RBP-Jκ but does not require HES1, and activated NOTCH2 can reprogram adult hepatocytes into biliary cells with tubular-cystic structures.\",\n      \"method\": \"Genetic mouse models with N2IC transgene, RBP-Jκ and HES1 conditional knockouts, liver histology, lineage tracing\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic mouse models with rigorous epistasis analysis; 77 citations\",\n      \"pmids\": [\"23315998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NOTCH2 and NOTCH3 signaling is activated by both Delta- and Jagged-type ligands and requires sequential cleavage by ADAM10 metalloprotease and then presenilin-1 or -2 (γ-secretase); ADAM17/TACE plays no role in ligand-induced NOTCH2 signaling.\",\n      \"method\": \"Cell-based signaling assays with ADAM10 and ADAM17 knockdown/inhibition, presenilin knockdown, ligand stimulation assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic dissection with multiple protease inhibitors and genetic knockdowns; 69 citations\",\n      \"pmids\": [\"24842903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In a Kras(G12D)-driven NSCLC mouse model, Notch2 deletion dramatically increases carcinogenesis and decreases differentiation associated with upregulation of β-catenin, whereas Notch1 deletion reduces tumor formation; Notch2-deficient tumors show increased MAPK activity and undifferentiated morphology, demonstrating a tumor-suppressive differentiation function for Notch2 in vivo.\",\n      \"method\": \"Conditional Notch1 and Notch2 knockout in Kras(G12D) NSCLC model, tumor burden analysis, immunohistochemistry, MAPK activity assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional knockout in an endogenous cancer model with multiple molecular readouts; 69 citations\",\n      \"pmids\": [\"24509876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NOTCH2 ICD physically interacts with TRAF6, and this interaction suppresses the TRAF6-AKT signaling axis, thereby inhibiting EMT and metastasis in nasopharyngeal carcinoma.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, immunofluorescence, mouse metastasis model, NOTCH2 overexpression/knockdown\",\n      \"journal\": \"Journal of Experimental & Clinical Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP demonstrating physical interaction plus functional rescue; single lab\",\n      \"pmids\": [\"31699119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The intracellular domains of NOTCH1 and NOTCH2 are functionally equivalent when swapped in vivo; differences in outcomes attributed to each receptor reflect differences in signal strength (number of NICD molecules reaching the nucleus) and duration (NICD-RBPjk-MAML-DNA complex half-life), not ICD amino acid composition. Tissue-specific γ-secretase complexes influence NICD stability.\",\n      \"method\": \"In vivo ICD-swap knock-in mice analyzed across multiple tissue contexts (T cells, skin, inner ear, lung, retina), biochemical half-life measurements\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vivo genetic swap across multiple tissue contexts with biochemical validation; 76 citations\",\n      \"pmids\": [\"26062937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NOTCH2 inhibits PDGF-B-dependent vascular smooth muscle cell (VSMC) proliferation, and NOTCH2 expression is decreased by PDGF-B, while NOTCH3 promotes proliferation; NOTCH2 does not protect VSMCs from apoptosis or activate MAP kinase signaling (unlike NOTCH3), demonstrating distinct receptor-specific functions in VSMCs.\",\n      \"method\": \"NOTCH2 and NOTCH3 knockdown/overexpression in cultured VSMCs, proliferation assay, apoptosis assay, MAP kinase signaling analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays with defined molecular pathway analysis; single lab\",\n      \"pmids\": [\"25957400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Notch2 signaling in the ocular lens blocks lens progenitor cell death (apoptosis), regulates cell cycle withdrawal, and is required for secondary fiber cell differentiation; loss of Notch2 but not another receptor accounts for this function, establishing a specific requirement for Notch2 in lens morphogenesis.\",\n      \"method\": \"Conditional Notch2 knockout in lens, histology, TUNEL, BrdU, gene expression (Cdkn1a, Ccnd2, Cdh1)\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional knockout with defined molecular and cellular phenotypes, multiple readouts\",\n      \"pmids\": [\"22173065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Id4 is a direct downstream target of NOTCH2 signaling in adult hippocampal neural stem cells (NSCs); Id4 promotes NSC quiescence by blocking cell-cycle entry, and Id4 knockdown rescues NOTCH2-induced inhibition of NSC proliferation, establishing a NOTCH2-Id4 axis that maintains NSC quiescence.\",\n      \"method\": \"Conditional Notch2 knockout, Id4 knockdown, Id4 overexpression, BrdU labeling, flow cytometry, gene expression analysis in mouse hippocampus\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo epistasis with loss and gain of function, multiple genetic interventions; 80 citations\",\n      \"pmids\": [\"31390563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Midkine binds Notch2 (identified as a candidate midkine receptor) and activates NOTCH2-HES1 signaling in neuroblastoma; midkine deficiency in MYCN-transgenic mice reduces Notch2 activation and delays tumor formation, and midkine RNA aptamer suppresses NOTCH2-HES1 signaling and tumor growth.\",\n      \"method\": \"Midkine genetic knockout in MYCN-transgenic mice, RNA aptamer treatment, xenograft, immunostaining for Notch2/HES1\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic and pharmacological approaches; receptor identification not fully confirmed biochemically\",\n      \"pmids\": [\"23243020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DLL1 expressed on differentiating satellite cells signals through NOTCH2 on neighboring satellite cells to maintain satellite cell self-renewal during muscle regeneration; antagonistic antibodies against DLL1 and NOTCH2 block self-renewal, establishing this ligand-receptor pair as required for proportional muscle regeneration.\",\n      \"method\": \"Single-cell RNA sequencing, in vivo antagonistic antibody treatment, satellite cell fate tracking\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo antibody-mediated functional blockade with single-cell resolution characterization; 51 citations\",\n      \"pmids\": [\"32023464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Lunatic fringe (LFNG) modification of O-fucose on EGF8 and EGF12 of NOTCH2 enhances DLL1-NOTCH2 activation; Manic fringe (MFNG) inhibits NOTCH2 activation by JAG1 and JAG2; elimination of O-fucose on EGF12 allows LFNG to inhibit JAG1-NOTCH2, and O-fucosylation on EGF9 is important for NOTCH2 trafficking to the cell surface.\",\n      \"method\": \"Cell-based Notch signaling and ligand-binding assays, site-directed mutagenesis, mass spectrometry of O-fucose sites, GXYLT1/GXYLT2 double knockout cells\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution assays combined with mutagenesis and mass spectrometry; 59 citations\",\n      \"pmids\": [\"32820046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Xylosyl elongation of O-glucose glycans on NOTCH2 EGF repeats by GXYLT1 and GXYLT2 promotes cell surface trafficking of overexpressed NOTCH2; GXYLT1/GXYLT2 double knockout reduces secretion of NOTCH2 ECD, indicating a role for O-Glc elongation in quality control of NOTCH2.\",\n      \"method\": \"Mass spectrometry of O-Glc glycans on all 17 EGF repeats, GXYLT1/GXYLT2 double knockout cells, cell surface expression assay, in vitro secretion assay\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive mass spectrometry combined with genetic knockout and functional trafficking assays\",\n      \"pmids\": [\"32423029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Induced Notch2IC expression in mature follicular B (FoB) cells re-programs them into bona fide marginal zone B (MZB) cells (confirmed by surface phenotype, localization, immunological function, and transcriptome), demonstrating Notch2 activation as a singular event sufficient to drive FoB-to-MZB trans-differentiation.\",\n      \"method\": \"Inducible Notch2IC transgene expression in FoB cells in immunocompetent wildtype mice, flow cytometry, transcriptomics, functional immunological assays\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gain-of-function with multiple orthogonal validation methods; 36 citations\",\n      \"pmids\": [\"33597542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In vivo Notch2 blockade in marginal zone (MZ) B cells reverses division-independent plasma cell differentiation and decreases mTORC1- and Myc-regulated gene transcription; Notch2/mTORC1 signaling in MZ B cells establishes a unique cellular state enabling rapid mitosis-independent plasma cell generation.\",\n      \"method\": \"Short-term in vivo Notch2 blockade with antibodies, Myc conditional deletion, ectopic mTORC1 activation in follicular B cells, plasma cell differentiation assays\",\n      \"journal\": \"Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo pharmacological blockade plus genetic epistasis with multiple functional readouts\",\n      \"pmids\": [\"34473651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Multinucleated myofibers express Notch2; in disuse and diabetes-induced muscle atrophy, microvascular endothelium upregulates and releases the Notch ligand Dll4, which activates muscular Notch2 without direct cell-cell contact. Inhibition of Dll4-Notch2 axis prevents muscle atrophy and promotes hypertrophy in mice.\",\n      \"method\": \"Conditional Notch2 knockout in muscle fibers, Dll4 antibody blockade, mouse models of disuse and diabetes-induced atrophy, muscle mass and fiber-type analysis\",\n      \"journal\": \"Nature Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional knockout plus ligand blockade with defined mechanistic and phenotypic readouts; 40 citations\",\n      \"pmids\": [\"35228746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KLHL6 is an E3 ubiquitin ligase that targets plasma membrane-associated NOTCH2 for proteasome-dependent degradation; DLBCL-associated NOTCH2 mutations result in a protein that escapes KLHL6-mediated ubiquitin-dependent proteolysis, leading to protein stabilization and activation of oncogenic RAS signaling.\",\n      \"method\": \"CRISPR-Cas9 cullin-RING ligase library screen, proteomic identification of KLHL6-NOTCH2 interaction, proteasome inhibition, mutation analysis in CHOP-resistant DLBCL\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — unbiased CRISPR screen combined with proteomics and mechanistic validation of ubiquitin-mediated degradation; 22 citations\",\n      \"pmids\": [\"37235754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DTX3 (Deltex E3 ubiquitin ligase 3) was identified by yeast two-hybrid screening as a novel E3 ligase for NOTCH2 and promotes NOTCH2 ubiquitination and degradation in esophageal carcinoma cells.\",\n      \"method\": \"Yeast two-hybrid screening, Co-immunoprecipitation, ubiquitination assay, knockdown/overexpression functional studies\",\n      \"journal\": \"Cancer Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid identification confirmed by Co-IP and ubiquitination assay; single lab\",\n      \"pmids\": [\"31854042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"N-acetylcysteine (NAC) promotes NOTCH2 degradation through an Itch-dependent lysosomal pathway in glioblastoma cells, independent of its antioxidant function, thereby reducing downstream HES1 and HEY1 expression.\",\n      \"method\": \"Western blot, lysosome inhibitors, Itch E3 ligase co-expression, cell-based assays in glioblastoma\",\n      \"journal\": \"Journal of Experimental & Clinical Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway identified with pharmacological and genetic tools; single lab\",\n      \"pmids\": [\"30606241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MINAR1 (major intrinsically disordered Notch2-associated receptor 1) physically interacts with NOTCH2, increases NOTCH2 stability and function, and inhibits angiogenesis and breast cancer growth; MINAR1 is an intrinsically disordered protein with a single transmembrane domain expressed in breast epithelium and endothelium.\",\n      \"method\": \"Co-immunoprecipitation, overexpression/knockdown, in vitro angiogenesis assay, zebrafish angiogenesis model, mouse matrigel plug, xenograft\",\n      \"journal\": \"Journal of Molecular Cell Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP demonstrating physical interaction with multiple in vitro and in vivo functional readouts; single lab\",\n      \"pmids\": [\"29329397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SCF induces Notch2 expression in human erythroblasts; functional inhibition of Notch2 or its ligand Jagged1 blocks SCF-driven erythroblast expansion and delays differentiation; dominant-negative Notch2 inhibits basal and SCF-mediated erythroblast proliferation, placing Notch2-Jagged1 signaling downstream of c-kit in SCF-mediated erythropoiesis.\",\n      \"method\": \"Dominant-negative Notch2 transduction in primary erythroblasts, Notch/Jagged1 functional inhibition, erythroblast expansion and differentiation assays\",\n      \"journal\": \"Cell Death and Differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis using dominant-negative approach in primary human cells; single lab\",\n      \"pmids\": [\"20829885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BCL6 directly binds and represses NOTCH2 and Notch pathway gene promoters in follicular lymphoma (FL) cells; inducible Notch2 expression abrogates GC formation in mice and kills FL cells; BCL6 inhibition leads to NOTCH2 induction and FL cell death, rescued by NOTCH2 depletion — establishing BCL6 repression of NOTCH2 as essential for FL survival.\",\n      \"method\": \"ChIP-seq of BCL6 binding in primary FL cells, inducible Notch2 expression in mice, BCL6 inhibitors in xenografts and primary FL, NOTCH2 depletion rescue experiments\",\n      \"journal\": \"Cancer Discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq plus multiple in vivo genetic and pharmacological interventions with rescue; 39 citations\",\n      \"pmids\": [\"28232365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NOTCH2 blockade reduces CXCR4 expression on hematopoietic stem cells (HSCs), and NOTCH2 (via its transcriptional partner RBPJ) directly regulates CXCR4 transcription; Notch2 blockade or deficiency leads to decreased HSC quiescence, enhanced egress from marrow, and transient myeloid progenitor expansion.\",\n      \"method\": \"NOTCH2 blocking antibodies, Notch2 conditional knockout mice, RBPJ ChIP at CXCR4 promoter, flow cytometry of HSCs and progenitors\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct RBPJ binding at CXCR4 promoter, combined with in vivo genetic and antibody approaches\",\n      \"pmids\": [\"28729299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Notch2 signaling is specifically required for cytokine-induced goblet cell metaplasia in airway epithelial cells; inhibition of Notch2 (but not other Notch receptors) prevents goblet cell metaplasia induced by inflammatory cytokines both in vitro (3D culture system) and in vivo.\",\n      \"method\": \"3D airway epithelial culture screen, Notch2-specific antibody inhibition, in vivo mouse model of goblet cell metaplasia\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro screen validated in vivo with receptor-specific antibody; 200 citations\",\n      \"pmids\": [\"25558064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In antigen-activated follicular B cells, high NOTCH2 signaling drives MZB cell fate or plasmablast differentiation, while cells that turn off NOTCH2 signaling enter germinal centers; NOTCH2 signaling governs expansion of IgG1+ germinal center B cells and controls a binary fate decision between GCB and MZB cell fates.\",\n      \"method\": \"Notch2 conditional ablation and constitutive activation upon immunization, mathematical modeling, flow cytometry, B cell fate tracking\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic loss and gain of function with quantitative modeling; 14 citations\",\n      \"pmids\": [\"38438375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The lncRNA LINC01977 physically binds RBM39 to prevent ubiquitination and degradation of NOTCH2, promoting its nuclear entry and HCC progression; IGF2BP2 (an m6A reader) stabilizes LINC01977 mRNA to maintain high levels in HCC.\",\n      \"method\": \"RNA immunoprecipitation, Co-IP, ubiquitination assay, nuclear fractionation, loss/gain-of-function in vitro and in vivo\",\n      \"journal\": \"Cell Death Discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical assays; single lab study\",\n      \"pmids\": [\"37198207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The pan-cancer 3'-tRF CAT1 binds RBPMS and displaces NOTCH2 mRNA from RBPMS, thereby inhibiting CCR4-NOT deadenylation complex-mediated NOTCH2 mRNA decay and increasing NOTCH2 expression to promote lung cancer cell proliferation and metastasis.\",\n      \"method\": \"RNA immunoprecipitation, RNA decay assay, CAT1 overexpression/knockdown, RBPMS knockdown, in vitro and in vivo tumor models\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA-protein interaction mechanism with functional validation in vitro and in vivo; single lab\",\n      \"pmids\": [\"37943661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Gm364 (a multi-pass transmembrane protein) directly binds and anchors the ubiquitin ligase MIB2 on the membrane; membrane MIB2 ubiquitinates and activates DLL3; activated DLL3 binds and activates Notch2, generating NICD2 that activates AKT within the cytoplasm to regulate oocyte meiosis and quality.\",\n      \"method\": \"Global Gm364 knockout in mice, Co-immunoprecipitation, ubiquitination assay, NICD2 detection, AKT activation assay, follicle and oocyte phenotyping\",\n      \"journal\": \"Cell Death and Differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo knockout with biochemical pathway dissection; single lab\",\n      \"pmids\": [\"34635817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Jagged-1 (JAG1)/Notch2 signaling in the liver is antagonized by Delta-like 4 (Dll4)/Notch1 signaling; Jag1 deletion in desmin-positive mesenchymal cells during chemical hepatocarcinogenesis induces ectopic Dll4 expression in hepatocytes with loss of Notch2 signaling, leading to tumor progression.\",\n      \"method\": \"Hepatocyte-specific Dll4 knockout, Jag1 deletion, diethylnitrosamine-induced hepatocarcinogenesis model, immunostaining, Notch pathway target analysis\",\n      \"journal\": \"Communications Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional knockouts with epistatic analysis; single lab\",\n      \"pmids\": [\"35064244\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOTCH2 is a type I transmembrane receptor that, upon ligand (DLL or Jagged family) binding, undergoes sequential proteolytic cleavage by ADAM10 and γ-secretase (presenilin-1/2) to release its intracellular domain (N2ICD), which translocates to the nucleus, interacts with the transcriptional repressor RBPJ/CBF1 to convert it into a transcriptional activator, and induces target genes (HES1, HEY family); the strength and duration of N2ICD nuclear signaling — modulated by extracellular O-fucosylation (Fringe enzymes), cell-surface abundance (regulated by the NECD and glycosylation), and protein stability (controlled by ubiquitin ligases KLHL6 and DTX3 via proteasomal degradation) — determines context-specific outcomes including biliary epithelial specification, DC subset differentiation, marginal zone B cell fate, satellite cell self-renewal, muscle fiber homeostasis, NSC quiescence (via Id4), and osteoclastogenesis (via NF-κB/NFATc1 co-recruitment), while gain-of-function truncating mutations in NOTCH2 (as in Hajdu-Cheney syndrome and DLBCL) escape ubiquitin-dependent degradation to constitutively activate downstream oncogenic pathways.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NOTCH2 is a transmembrane receptor that transduces extracellular signals into transcriptional programs governing cell fate decisions across diverse tissues, including biliary specification, marginal zone B cell commitment, dendritic cell subset differentiation, neural stem cell quiescence, satellite cell self-renewal, and osteoclastogenesis. Upon binding Delta or Jagged family ligands, NOTCH2 undergoes sequential proteolytic cleavage by ADAM10 and γ-secretase (presenilin-1/2) to release its intracellular domain (N2ICD), which enters the nucleus, converts the transcriptional repressor RBPJ/CBF1 into an activator, and induces context-dependent targets including HES1, NFATc1, Id4, and CXCR4 [PMID:9032325, PMID:24842903, PMID:18710934, PMID:31390563, PMID:28729299]. Signal strength is tuned by O-fucosylation (Fringe enzymes modulate ligand selectivity), O-glucose elongation (GXYLT1/GXYLT2 control surface trafficking), extracellular domain properties that govern cleavage efficiency, and protein turnover via the E3 ubiquitin ligases KLHL6 and DTX3 [PMID:32820046, PMID:32423029, PMID:23806616, PMID:37235754, PMID:31854042]. DLBCL-associated gain-of-function NOTCH2 mutations escape KLHL6-mediated degradation to constitutively activate oncogenic signaling, while activated NOTCH2 is sufficient to reprogram follicular B cells into marginal zone B cells and hepatocytes into biliary epithelial cells [PMID:37235754, PMID:33597542, PMID:23315998].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Identification of NOTCH2 as a second mammalian Notch receptor with distinct expression patterns from NOTCH1 established that multiple non-redundant Notch paralogs exist in mammals.\",\n      \"evidence\": \"cDNA cloning and Northern blot/in situ hybridization in rat tissues\",\n      \"pmids\": [\"1295745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional distinctions from NOTCH1 not yet demonstrated\", \"Ligands and downstream targets unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstration that NOTCH2 ICD binds RBPJ/CBF1, translocates to the nucleus, and activates HES1 transcription established the core canonical signaling mechanism shared with NOTCH1.\",\n      \"evidence\": \"Co-immunoprecipitation, nuclear localization assay, luciferase reporters, and myoblast differentiation blockade\",\n      \"pmids\": [\"9032325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream proteolytic activation events not defined\", \"Whether NOTCH2 has unique transcriptional targets beyond HES1 unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showing that loss of NOTCH2 ankyrin repeats causes embryonic lethality with neural apoptosis — distinct from NOTCH1 somitogenesis defects — proved non-redundant in vivo requirements.\",\n      \"evidence\": \"Knock-in deletion of ankyrin repeats in mice with TUNEL and histological analysis\",\n      \"pmids\": [\"10393120\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific cell types requiring NOTCH2 not resolved\", \"Downstream effectors of NOTCH2 in neural survival unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Constitutively active NOTCH2 promoted brain tumor cell proliferation while NOTCH1 inhibited it, revealing that Notch paralogs can have opposing oncogenic versus tumor-suppressive roles in the same cellular context.\",\n      \"evidence\": \"Truncated ICD expression in embryonal brain tumor lines with soft agar and xenograft assays\",\n      \"pmids\": [\"15520184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for opposite effects of NOTCH1 vs NOTCH2 ICD not identified\", \"Relevance to spontaneous human tumors not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery that NOTCH2 ICD physically interacts with NF-κB p65 and is co-recruited to the NFATc1 promoter during osteoclastogenesis revealed a non-canonical co-activator mechanism linking NOTCH2 to bone resorption.\",\n      \"evidence\": \"ChIP, Co-IP, γ-secretase inhibition, and shRNA knockdown in RANKL-stimulated bone marrow macrophages\",\n      \"pmids\": [\"18710934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NOTCH2-NF-κB interaction occurs in other cell types unknown\", \"Structural basis of the interaction not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Conditional NOTCH2 ICD expression converted hepatoblasts into biliary epithelial cells and induced ectopic bile ducts, establishing NOTCH2 as a direct fate switch for intrahepatic biliary specification.\",\n      \"evidence\": \"Conditional transgenic mouse with liver-specific Notch2ICD, bile duct morphometry\",\n      \"pmids\": [\"19551907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional program executing biliary fate not fully mapped\", \"Relationship to RBPJ dependence not tested in this study\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"DC-specific NOTCH2 deletion ablated Esam-hi CD11b+ splenic DCs and intestinal CD103+ DCs, identifying NOTCH2 as the receptor required for T cell-priming DC subset differentiation.\",\n      \"evidence\": \"DC-specific conditional Notch2 knockout with flow cytometry and T cell priming assays\",\n      \"pmids\": [\"22018469\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ligand source and identity for DC differentiation not identified\", \"NOTCH2 target genes in DC progenitors unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"ICD-swap knock-in mice revealed that NOTCH2 specificity in proximal nephron development arises from differences in extracellular domain properties (surface abundance, cleavage efficiency, Fringe modulation) rather than ICD identity, fundamentally reframing paralog specificity as a signal-strength problem.\",\n      \"evidence\": \"ICD-swap knock-in mice, cell surface quantification, ligand cleavage assays with Fringe co-expression\",\n      \"pmids\": [\"23806616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for differential ECD cleavage efficiency not resolved\", \"Whether this principle generalizes to all tissues not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"NOTCH2-driven biliary reprogramming was shown to require RBPJ but not HES1, proving that HES1-independent RBPJ targets mediate biliary fate.\",\n      \"evidence\": \"Epistasis analysis using N2IC transgene with RBPJ and HES1 conditional knockouts in mouse liver\",\n      \"pmids\": [\"23315998\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the critical RBPJ-dependent, HES1-independent targets unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Enzymatic dissection showed that ligand-induced NOTCH2 activation requires ADAM10 (not ADAM17) followed by presenilin-dependent γ-secretase cleavage, defining the obligate protease cascade.\",\n      \"evidence\": \"Cell-based signaling assays with ADAM10/ADAM17 knockdown and presenilin inhibition\",\n      \"pmids\": [\"24842903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether tissue-specific γ-secretase complexes differentially process NOTCH2 in vivo not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"In vivo ICD-swap across multiple tissues confirmed that NOTCH1 and NOTCH2 ICDs are functionally equivalent; paralog-specific outcomes arise from differences in NICD nuclear concentration and half-life, influenced by tissue-specific γ-secretase composition.\",\n      \"evidence\": \"Multi-tissue analysis of ICD-swap knock-in mice with biochemical half-life measurements\",\n      \"pmids\": [\"26062937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of tissue-specific γ-secretase modulators unknown\", \"How NICD half-life is set at the structural level not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of Id4 as a direct NOTCH2 target in hippocampal neural stem cells, with epistatic rescue, established a NOTCH2→Id4 axis maintaining adult NSC quiescence.\",\n      \"evidence\": \"Conditional Notch2 knockout, Id4 knockdown rescue, BrdU labeling in mouse hippocampus\",\n      \"pmids\": [\"31390563\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Id4 is the sole mediator of NOTCH2-dependent quiescence not excluded\", \"Chromatin-level mechanism of Id4 activation not shown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"DLL1 on differentiating satellite cells was shown to signal through NOTCH2 on quiescent neighbors to maintain self-renewal during muscle regeneration, defining the ligand-receptor pair governing proportional stem cell maintenance.\",\n      \"evidence\": \"Single-cell RNA-seq and in vivo antagonistic antibody treatment against DLL1 and NOTCH2\",\n      \"pmids\": [\"32023464\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional targets of NOTCH2 in satellite cells not identified\", \"Whether other ligands contribute remains untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Comprehensive glycosylation analysis revealed that Fringe enzymes modulate NOTCH2 ligand selectivity (LFNG enhances DLL1 response; MFNG inhibits JAG1/JAG2) through O-fucose modifications on specific EGF repeats, and O-glucose elongation by GXYLT1/GXYLT2 controls NOTCH2 surface trafficking.\",\n      \"evidence\": \"Mass spectrometry of O-fucose/O-glucose sites, site-directed mutagenesis, cell-based signaling assays, GXYLT1/GXYLT2 knockout\",\n      \"pmids\": [\"32820046\", \"32423029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of individual glycosylation sites not tested\", \"How glycosylation affects NOTCH2 folding/quality control at atomic resolution unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Activated NOTCH2 was shown to be both necessary and sufficient for marginal zone B cell fate: induced N2ICD reprogrammed follicular B cells into functional MZB cells, and NOTCH2 signaling maintained MZB identity by sustaining mTORC1/Myc programs enabling division-independent plasmablast differentiation.\",\n      \"evidence\": \"Inducible N2ICD transgene in FoB cells, in vivo NOTCH2 antibody blockade, Myc conditional deletion, flow cytometry, transcriptomics\",\n      \"pmids\": [\"33597542\", \"34473651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NOTCH2 integrates with BCR signaling to make the binary GCB vs MZB decision not fully resolved\", \"Direct transcriptional targets mediating mTORC1 activation unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Endothelium-derived DLL4 was shown to activate NOTCH2 on mature myofibers in a non-contact-dependent manner to drive muscle atrophy in disuse and diabetes, establishing a paracrine NOTCH2 role in post-developmental muscle homeostasis.\",\n      \"evidence\": \"Conditional Notch2 knockout in muscle fibers, DLL4 antibody blockade, disuse and diabetes mouse models\",\n      \"pmids\": [\"35228746\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of non-contact DLL4 delivery (e.g. exosomes vs soluble cleavage) not defined\", \"NOTCH2 transcriptional targets driving atrophy gene program unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"An unbiased CRISPR screen identified KLHL6 as the E3 ubiquitin ligase targeting membrane-associated NOTCH2 for proteasomal degradation; DLBCL-associated NOTCH2 mutations escape this degradation, directly linking NOTCH2 protein stability control to lymphomagenesis.\",\n      \"evidence\": \"CRISPR cullin-RING ligase library screen, proteomics, proteasome inhibition, DLBCL mutation analysis\",\n      \"pmids\": [\"37235754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for how DLBCL mutations evade KLHL6 recognition unknown\", \"Whether KLHL6 regulation operates in non-B cell contexts not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Quantitative in vivo analysis showed that NOTCH2 signal level governs a binary fate decision in antigen-activated B cells: high NOTCH2 drives MZB/plasmablast fate while signal extinction permits germinal center entry.\",\n      \"evidence\": \"Conditional ablation and constitutive activation upon immunization, mathematical modeling, B cell fate tracking\",\n      \"pmids\": [\"38438375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What tunes NOTCH2 signal level in individual B cells is not defined\", \"Whether this binary switch model applies in chronic infection or autoimmunity unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for differential ECD-mediated signal strength between NOTCH paralogs; the identity of NOTCH2-specific transcriptional targets (beyond HES1/Id4/NFATc1) in most tissue contexts; how tissue-specific γ-secretase complexes tune NICD stability; and the full spectrum of E3 ligases controlling NOTCH2 turnover across cell types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of NOTCH2 ECD-ligand complexes exists\", \"Comprehensive ChIP-seq for N2ICD/RBPJ across tissues is lacking\", \"Relative contributions of proteasomal vs lysosomal degradation pathways in vivo not systematically compared\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 3, 5, 11, 18]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 12, 20, 21]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [10, 21, 22, 26]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 5, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [1, 5, 11, 18, 31, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 12, 20, 21, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 7, 8, 10, 23]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7, 23, 24, 34]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 13, 26, 31]}\n    ],\n    \"complexes\": [\n      \"NOTCH2-RBPJ/CBF1-MAML transcription complex\",\n      \"γ-secretase (presenilin-containing) complex\"\n    ],\n    \"partners\": [\n      \"RBPJ\",\n      \"ADAM10\",\n      \"DLL1\",\n      \"JAG1\",\n      \"KLHL6\",\n      \"DTX3\",\n      \"RELA\",\n      \"MINAR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}